BTG1 and non-small cell lung carcinoma: Among all patients with NSCLC, DFS was worse in patients who had low plasma exosome-derived BTG-1 levels compared with that in patients with high plasma exosome-derived BTG-1 levels (P < 0.001; Figure 3A).